Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway

Ítems similars

• Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
  per: Ling Li, et al.
  Publicat: (2020-09-01)
• ERK inhibition effectively overcomes acquired resistance of EGFR-mutant NSCLC cells to osimertinib
  per: Li, Yiting, et al.
  Publicat: (2019)
• Repositioning Aspirin to Treat Lung and Breast Cancers and Overcome Acquired Resistance to Targeted Therapy
  per: Li, Ling, et al.
  Publicat: (2020)
• Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer—an option for overcoming EGFR-TKI resistance
  per: Han, Ruoshuang, et al.
  Publicat: (2021)
• NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor
  per: Galvani, Elena, et al.
  Publicat: (2015)